Axsome Therapeutics, Inc. (AXSM)
175.88
-6.76
(-3.70%)
USD |
NASDAQ |
Jan 02, 12:54
Axsome Therapeutics Research and Development Expense (TTM): 188.68M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Fortress Biotech, Inc. | 22.21M |
| TG Therapeutics, Inc. | 142.90M |
| Karyopharm Therapeutics, Inc. | 130.89M |